Skip to main content
Premium Trial:

Request an Annual Quote

RareCyte Arv7/Synaptophysin Panel Kit

RareCyte's Arv7/Synaptophysin Panel Kit is a research-use-only dual-biomarker liquid biopsy assay for androgen receptor splice variant 7 (Arv7) and the neuroendocrine marker synaptophysin (SYP) that enables customers to evaluate the expression of both biomarkers on circulating tumor cells from prostate cancer patients. The assay comprises processing blood to slides with the AccuCyte Sample Preparation System followed by staining with the ARv7/Synaptophysin kit and imaging on a CyteFinder instrument. Machine learning-enabled analysis and scoring maximizes reviewer concordance. In addition, the RareCyte platform enables cell-free DNA analysis on the same sample, providing a comprehensive liquid biopsy assessment of tumor status, the company said.

The Scan

Boosters Chasing Variants

The New York Times reports that an FDA advisory panel is to weigh updated booster vaccines for COVID-19.

Not Yet

The World Health Organization says monkeypox is not yet a global emergency, the Washington Post reports.

More Proposed for Federal Research

Science reports that US House of Representatives panels are seeking to increase federal research funding.

PLOS Papers on Breast Cancer Metastasis, Left-Sided Cardiac Defects, SARS-CoV-2 Monitoring

In PLOS this week: link between breast cancer metastasis and CLIC4, sequencing analysis of left-sided cardiac defects, and more.